Could a stroke drug fix chemo brain? new trial hopes so
NCT ID NCT07454473
First seen Mar 08, 2026 · Last updated May 05, 2026 · Updated 5 times
Summary
This study tests a sublingual tablet (Edaravone and Dexborneol) to treat 'chemo brain'—memory and thinking problems after chemotherapy. About 80 adults who had chemotherapy will take the tablet to see if it improves their cognitive symptoms. The drug aims to reduce brain inflammation and damage, which may help restore mental clarity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMO BRAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of China Medical University
RECRUITINGShenyang, Liaoning, 110000, China
Conditions
Explore the condition pages connected to this study.